Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. (Q43566895)
Jump to navigation
Jump to search
scientific article published in March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. |
scientific article published in March 2001 |
Statements
Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma (English)
C Twelves
M Findlay
J Cassidy
C Weitzel
C Barker
B Osterwalder
C Jamieson
K Hieke
Xeloda Colorectal Cancer Study Group